Vaginal Rejuvenation Market Growth & Trends
The global vaginal rejuvenation market is expected to reach USD 4.7 billion by 2030, according to a new report by Grand View Research, Inc. The Growing popularity of vaginal rejuvenation surgery due to the risi
Please note The report will be delivered in 2-3 business days upon order notification.
- Chapter 1 Research Methodology and Scope
- 1.1 Research Process
- 1.2 Information Procurement
- 1.2.1 Purchased database:
- 1.2.1.1 GVR’s internal database
- 1.2.2 Market Formulation & Validation
- 1.3 Research Methodology
- 1.4 Research Scope and Assumptions
- 1.5 List to Data Sources
- Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
- 2.4 The U.S. Cannabis Market Snapshot
- Chapter 3 U.S. Cannabis Market Variables, Trends & Scope
- 3.1 Market Segmentation
- 3.2 Penetration and Growth Prospect Mapping
- 3.3 The U.S. Cannabis Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.2 Market Restraints Analysis
- 3.3.4 Opportunity Analysis (2016-2021-2030)
- 3.3.5 The U.S. Cannabis Industry Case Study
- 3.3.5.1 Legalization of Cannabis:
- 3.3.5.2 Reason for Legalization:
- 3.3.5.3 Scenario After Legalization and Consumer Attitudes:
- 3.3.5.4 Competitive Landscape Post Legalization:
- 3.3.6 The U.S. Cannabis Regulatory Scenario
- 3.3.7 The U.S. Cannabis Market - PESTLE Analysis
- 3.3.8 Industry Analysis - Porter’s
- Chapter 4 U.S. Cannabis Market: End-Use Estimates & Trend Analysis
- 4.1 Cannabis Market: End-Use Movement Analysis
- 4.2 Medical
- 4.2.1 Medical market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.2.2 Cancer
- 4.2.2.1 Cancer Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.3. Chronic Pain
- 4.2.3.1 Chronic Pain Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.4 Depression And Anxiety
- 4.2.4.1 Depression And Anxiety Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.5 Arthritis
- 4.2.5.1 Arthritis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.6 Diabetes
- 4.2.6.1 Diabetes Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.7 Glaucoma
- 4.2.7.1 Glaucoma Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.8 Migraines
- 4.2.8.1 Migraines Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.9 Epilepsy
- 4.2.9.1 Epilepsy Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.10 Multiple Sclerosis
- 4.2.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.11 AIDS
- 4.2.11.1 AIDS Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.12 Amyotrophic Lateral Sclerosis
- 4.2.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.13 Alzheimer's
- 4.2.13.1 Alzheimer's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.14 Post Traumatic Stress Disorder (Ptsd)
- 4.2.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.15 Parkinson's
- 4.2.15.1 Parkinson's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.16 Tourette’s
- 4.2.16.1 Tourette’s Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.2.17 Others
- 4.2.17.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 4.3 Recreational
- 4.3.1 Recreational market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.4 Industrial
- 4.4.1 Industrial market estimates and forecasts, 2016 - 2030 (USD Million)
- Chapter 5 U.S. Cannabis Market: Source Type Estimates & Trend Analysis
- 5.1 U.S. Cannabis Market: Source Type Movement Analysis
- 5.2 Marijuana
- 5.2.1 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.2.2 Flowers
- 5.2.2.1 Flowers Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 5.2.3 Oil And Tinctures
- 5.2.3.1 Oil And Tinctures Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 5.3 Hemp
- 5.3.1 Hemp market estimates and forecasts, 2016- 2030 (USD Million)
- 5.3.2 Hemp CBD
- 5.3.2.1 Hemp CBD Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 5.3.3 Supplements
- 5.3.3.1 Supplements Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- 5.3.4. Industrial Hemp
- 5.3.4..1 Industrial Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)
- Chapter 6 U.S. Cannabis Market: Derivative Estimates & Trend Analysis
- 6.1 U.S. Cannabis Market: Derivative Movement Analysis
- 6.2 CBD
- 6.2.1 CBD market estimates and forecasts, 2016 – 2030 (USD Million)
- 6.3 THC
- 6.3.1 CBD market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.4 Others
- 6.4.1 Other market estimates and forecasts, 2016 - 2030 (USD Million)
- Chapter 7 Competitive Landscape
- 7.1 Company Profiles
- 7.1.1 CANOPY GROWTH CORPORATION
- 7.1.1.1 Funding
- 7.1.1.2 Number of Employees
- 7.1.1.3 Headquarters
- 7.1.1.4 Business Model (Product Offerings)
- 7.1.1.5 Growers, Manufacturers, Retailers
- 7.1.1.6 Revenue 2020(USD Mn)
- 7.1.1.7 Net Loss 2020 (USD Mn
- 7.1.1.8 Valuation (USD Mn)
- 7.1.1.9 Regions With Commercial Presence
- 7.1.2 GW PHARMACEUTICALS, PLC
- 7.1.2.1 Funding
- 7.1.2.2 Number of Employees
- 7.1.2.3 Headquarters
- 7.1.2.4 Business Model (Product Offerings)
- 7.1.2.5 Growers, Manufacturers, Retailers
- 7.1.2.6 Revenue 2020(USD Mn)
- 7.1.2.7 Net Loss 2020 (USD Mn
- 7.1.2.8 Valuation (USD Mn)
- 7.1.2.9 Regions With Commercial Presence
- 7.1.3 AURORA CANNABIS, INC.
- 7.1.3.1 Funding
- 7.1.3.2 Number of Employees
- 7.1.3.3 Headquarters
- 7.1.3.4 Business Model (Product Offerings)
- 7.1.3.5 Growers, Manufacturers, Retailers
- 7.1.3.6 Revenue 2020(USD Mn)
- 7.1.3.7 Net Loss 2020 (USD Mn
- 7.1.3.8 Valuation (USD Mn)
- 7.1.3.9 Regions With Commercial Presence
- 7.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)
- 7.1.4.1 Funding
- 7.1.4.2 Headquarters
- 7.1.4.3 Business Model (Product Offerings)
- 7.1.4.4 Growers, Manufacturers, Retailers
- 7.1.4.5 Valuation (USD Mn)
- 7.1.4.6 Regions With Commercial Presence
- 7.1.5 CRONOS GROUP
- 7.1.5.1 Funding
- 7.1.5.2 Number of Employees
- 7.1.5.3 Headquarters
- 7.1.5.4 Business Model (Product Offerings)
- 7.1.5.5 Growers, Manufacturers, Retailers
- 7.1.5.6 Revenue 2020(USD Mn)
- 7.1.5.7 Net Loss 2020 (USD Mn
- 7.1.5.8 Valuation (USD Mn)
- 7.1.5.9 Regions With Commercial Presence
- 7.1.6 TILRAY
- 7.1.6.1 Funding
- 7.1.6.2 Number of Employees
- 7.1.6.3 Headquarters
- 7.1.6.4 Business Model (Product Offerings)
- 7.1.6.5 Growers, Manufacturers, Retailers
- 7.1.6.6 Revenue 2020(USD Mn)
- 7.1.6.7 Net Loss 2020 (USD Mn
- 7.1.6.8 Valuation (USD Mn)
- 7.1.6.9 Regions With Commercial Presence
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook